|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||||||
|
||||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s149FA6BE-59B5-11EF-984B-DA9385CE164B&I=39IZM&T=&OP=Display&O=html&O1=15035796&O2=3790000000063617&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DPertuzumab%2520and%2520trastuzumab%2520emtansine%2520in%2520patients%2520with%2520HER2-amplified%2520metastatic%2520colorectal%2520cancer%253A%2520the%2520phase%2520II%2520HERACLES-B%2520trial%26rft.au%3DFenocchio%252C%2520Elisabetta%26rft.au%3DLonardi%252C%2520Sara%26rft.au%3DMartino%252C%2520Cosimo%26rft.au%3DSartore-Bianchi%252C%2520Andrea%26rft.date%3D2020-09-28%26rft.eissn%3D2059-7029%26rft.externalDBID%3DPMC7523198%26rft.genre%3Darticle%26rft.issue%3D5%26rft.jtitle%3DESMO%2520open%26rft.pub%3DBMJ%2520Publishing%2520Group%26rft.volume%3D5%26rft_id%3Dinfo%253Adoi%252F10.1136%252Fesmoopen-2020-000911%26rft_id%3Dinfo%253Apmid%252F32988996%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS-getFullTxt-object,2-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_20221021_LCL-getFullTxt-object,3-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_OILJ_LCL-getFullTxt-object,4-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_PNG_LCL-getFullTxt-object,5-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UL_LCL-getFullTxt-object,6-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UM_LCL-getFullTxt-object,7-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UP_LCL-getFullTxt-object,8-UNPAYWALL-getFullTxt-object,9-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,10-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,11-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,12-MISCELLANEOUS_FREE_EJOURNALS-getFullTxt-object,13-DOI-getDOI-object,14-COBIB_SI_LCL-getHolding-object,15-REFWORKS_EXPORT_TOOL-getReference-object,16-NCBI_PUBMED_FREE-getCitedRecord-object,17-GOOGLE_SCHOLAR_FREE-getWebSearch-object,18-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=2.25207&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15035796-s149FA6BE-59B5-11EF-984B-DA9385CE164B" timestamp="2024-08-13T22:46:15Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:3790000000063617</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial</jnl:atitle>
<jnl:jtitle>Esmo Open</jnl:jtitle>
<jnl:date>2020-09-00</jnl:date>
<jnl:spage>e000911</jnl:spage>
<jnl:epage>e000911</jnl:epage>
<jnl:issn>2059-7029</jnl:issn>
<jnl:volume>5</jnl:volume>
<jnl:issue>5</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2059-7029</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:e556455447e313998458537ccf265d2aa1b24f95</ctx:identifier>
<ctx:identifier>urn:UUID:s149FA6BE-59B5-11EF-984B-DA9385CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)